Operating Income (Loss) in USD of Skye Bioscience, Inc. from Q1 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Skye Bioscience, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2012 to Q3 2025.
  • Skye Bioscience, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$13.3M, a 167% decline year-over-year.
  • Skye Bioscience, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$53.9M, a 128% decline year-over-year.
  • Skye Bioscience, Inc. annual Operating Income (Loss) for 2024 was -$30.2M, a 13.1% increase from 2023.
  • Skye Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$34.7M, a 89.7% decline from 2022.
  • Skye Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$18.3M, a 133% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Skye Bioscience, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$53.9M -$13.3M -$8.3M -167% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 -$45.6M -$18.2M -$9.84M -117% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$35.8M -$11.8M -$5.61M -91.1% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$30.2M -$10.7M -$6.58M -161% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 -$23.6M -$4.97M +$19.7M +79.9% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 -$43.3M -$8.41M -$5.56M -196% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$37.8M -$6.15M -$3.05M -98.5% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$34.7M -$4.09M +$5.2M +56% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 -$39.9M -$24.7M -$21.8M -745% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$18.1M -$2.84M +$375K +11.7% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024
Q1 2023 -$18.5M -$3.1M -$212K -7.35% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 -$18.3M -$9.28M -$6.82M -277% 01 Oct 2022 31 Dec 2022 10-K 22 Mar 2024
Q3 2022 -$11.5M -$2.92M -$1.1M -60.6% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$10.4M -$3.22M -$1.39M -75.9% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 -$9M -$2.89M -$1.15M -66.2% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$7.85M -$2.46M -$1.14M -86.6% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$6.7M -$1.82M -$281K -18.3% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$6.42M -$1.83M -$609K -49.9% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$5.82M -$1.74M +$474K +21.4% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q4 2020 -$6.29M -$1.32M +$525K +28.5% 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2022
Q3 2020 -$6.81M -$1.54M -$35.1K -2.34% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$6.78M -$1.22M +$550K +31.1% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 -$7.33M -$2.21M -$696K -45.9% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 -$6.63M -$1.84M -$528K -40.2% 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 -$6.1M -$1.5M -$457K -43.8% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 -$5.65M -$1.77M -$691K -63.9% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 -$4.96M -$1.52M -$264K -21.1% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020
Q4 2018 -$4.69M -$1.32M -$329K -33.3% 01 Oct 2018 31 Dec 2018 10-K 23 Mar 2020
Q3 2018 -$4.36M -$1.05M -$284K -37.3% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$4.08M -$1.08M -$349K -47.8% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 -$3.73M -$1.25M +$129K +9.33% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019
Q4 2017 -$3.86M -$987K -$74.5K -8.16% 01 Oct 2017 31 Dec 2017 10-K 14 Mar 2019
Q3 2017 -$3.78M -$762K +$94.5K +11% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$3.88M -$731K +$751K +50.7% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018
Q1 2017 -$4.63M -$1.38M -$160K -13.1% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$4.47M -$912K +$242K +21% 01 Oct 2016 31 Dec 2016 10-K 19 Mar 2018
Q3 2016 -$4.71M -$856K +$40.1K +4.48% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$4.75M -$1.48M -$125K -9.25% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 -$4.63M -$1.22M -$311K -34.1% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q4 2015 -$4.32M -$1.15M +$547K +32.1% 01 Oct 2015 31 Dec 2015 10-K 10 Mar 2017
Q3 2015 -$4.86M -$896K -$38.7K -4.51% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 -$4.83M -$1.36M -$1.21M -849% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016
Q1 2015 -$3.61M -$910K -$880K -2923% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 -$2.73M -$1.7M -$1.7M 01 Oct 2014 31 Dec 2014 10-K 21 Mar 2016
Q3 2014 -$1.03M -$858K -$828K -2749% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015
Q2 2014 -$204K -$143K -$144K 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$60.7K -$30.1K -$33.7K -933% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015
Q4 2013 -$27K -$1.23K* +$4.96K 01 Nov 2013 31 Jan 2014 10-Q 17 Mar 2014
Q3 2013 -$31.9K -$30.1K 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 $744* +$837 01 May 2013 31 Jul 2013 10-Q 15 Sep 2014
Q1 2013 $3.61K +$4.16K 31 Jan 2013 30 Apr 2013 10-Q 05 Jun 2014
Q4 2012 -$6.19K 01 Nov 2012 31 Jan 2013 10-Q 17 Mar 2014
Q2 2012 -$93* 01 May 2012 31 Jul 2012 10-Q 16 Sep 2013
Q1 2012 -$550* 31 Jan 2012 30 Apr 2012 10-Q 27 Jun 2013

Skye Bioscience, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$30.2M +$4.54M +13.1% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$34.7M -$16.4M -89.7% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 -$18.3M -$10.5M -133% 01 Jan 2022 31 Dec 2022 10-K 22 Mar 2024
2021 -$7.85M -$1.56M -24.8% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$6.29M +$344K +5.18% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022
2019 -$6.63M -$1.94M -41.3% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021
2018 -$4.69M -$833K -21.6% 01 Jan 2018 31 Dec 2018 10-K 23 Mar 2020
2017 -$3.86M +$611K +13.7% 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019
2016 -$4.47M -$153K -3.56% 01 Jan 2016 31 Dec 2016 10-K 19 Mar 2018
2015 -$4.32M -$1.59M -58% 01 Jan 2015 31 Dec 2015 10-K 10 Mar 2017
2014 -$2.73M -$2.61M -2169% 01 Jan 2014 31 Dec 2014 10-K 21 Mar 2016
2013 -$120K -$125K -3025% 01 Jan 2013 31 Dec 2013 10-K 27 Mar 2015
2012 $4.12K 01 Nov 2011 31 Oct 2012 10-K 27 Jan 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.